Showing results (781-790 of 3,048) with videos related to
Sort By:
Pageof 305
Current Drug Targets|February 4, 2021
Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC TreatmentAyana R Kumar, Aswathy R Devan, Bhagyalakshmi Nair, et al.Current Drug Targets|January 13, 2022
Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug TargetsSuman Kumar Ray, Sukhes MukherjeeCurrent Drug Targets|January 17, 2022
Anti-Degenerative Effect of Melatonin on Intervertebral Disc: Protective Contribution against Inflammation, Oxidative Stress, Apoptosis, and AutophagyKarim Hemati, Mohammad Hossein Pourhanifeh, Iman Fatemi, et al.Current Drug Targets|December 9, 2021
Dysregulation of Lysyl Oxidases Expression in Diabetic Nephropathy and Renal Cell CarcinomaCarolina Añazco, Sebastián Cerro, Nicolás Pereira, et al.Current Drug Targets|February 27, 2014
Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's diseasePrinci Jain, Chandrabose Karthikeyan, N S Hari Narayana Moorthy, et al.Current Drug Targets|April 18, 2017
Advances and Challenges in Drug Design of PPARδ LigandsVinicius Goncalves Maltarollo, Thales Kronenberger, Bjorn Windshugel, et al.Current Drug Targets|January 28, 2012
Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatmentOrly Weinreb, Tamar Amit, Orit Bar-Am, et al.Current Drug Targets|October 26, 2011
Targeting nitrosative stress for neurovascular protection: new implications in brain diseasesRong-Rong Tao, Yue-Long Ji, Ying-Mei Lu, et al.Current Drug Targets|October 26, 2011
GABAB receptors-associated proteins: potential drug targets in neurological disorders?Rafael Lujan, Francisco CiruelaCurrent Drug Targets|April 20, 2012
Off-label drug use in paediatrics: a world-wide problemChristian LenkPageof 305